Innovassynth and Actylis will collaborate to allow Actylis to add Innovassynth’s portfolio of nucleosides to its range of critical raw materials.

Innovassynth is a custom development and manufacturing organization (CDMO) and a partner to pharma and drug discovery, life sciences, diagnostics, and material science companies worldwide.

Innovassynth has technological expertise and extensive experience in the field of chemistry, and they provide services from development to commercialization of products. Nucleic acid chemistry is one of Innovassynth’s core competencies, and they have gained a reputation for being a reliable commercial manufacturer of protected nucleosides, phosphoramidites, and reagents.

Innovassynth offers end-to-end manufacturing and a transparent supply chain for Phosphoramidites and a variety of nucleic acid reagents, which is a compelling proposition to customers lacking supply chain diversity. Innovassynth also has significant capability in process R&D, custom synthesis, & contract manufacturing of pharma intermediates, specialty chemicals, and organometallics for customers worldwide.

Actylis can offer complementary products to the Innovassynth range through its recently acquired GMP manufacturing capabilities in Europe and the U.S. Actylis provides local and global distribution in the U.S. and Europe through strategically located warehouses, supply chain and sales offices in over ten countries. In addition, Actylis can support its customer’s development projects through every milestone in the development cycle from R&D to commercial production.

“We are truly excited to partner with Actylis which will synergize our reach and offer our customers a wider range of solutions,” said, Hardik Joshipura, managing director and CEO of Innovassynth. “Due to its techno commercial expertise, global sales, and distribution network, Actylis has emerged as the trusted partner of choice. We are committed to providing high-quality products and services to our customers, and we believe this partnership is a step in the right direction.”

Gilles Cottier, CEO of Actylis, said, “We’ve worked with Innovassynth on several projects over the past couple of years and I’m continually impressed with their capabilities and quality management. They have become a critical outsourcing partner as our internal projects scale. Innovossynth’s backward integrated Phosphoramidite supply chain – all originating in India – from key starters to finished product brings unique value to our customers. Bringing the nucleoside offering to market, together, fills key continuity of supply challenge for our customers and reinforces our position as the partner of choice.”